Top of main content

2022 vs 2020: COVID-19 waves and policy responses

11/08/2022
Hot Topics
Mainland China Equity
Hong Kong SAR, China Equity

Key Takeaways

  • GDP slowed in Q2 but maintained a positive reading on the back of some recovery momentum in June
  • We expect China’s easing stance to remain for the rest of the year, helping to support a moderate rebound in H2

China data review (June 2022)

Activity generally saw a broad-based recovery in June with consumption seeing a stronger-than-expected boost partly due to tax cuts and subsidies. More policy easing may be needed to help mitigate headwinds and support an investment-led recovery in the coming quarters.

  • China GDP growth slowed to 0.4% y-o-y in Q2, but remained in positive territory as the economy grappled with its worst wave of COVID-19 to date. April and May bore the worst of the impact as June data showed stronger activity prints across the board, with the exception of a further drop in property investment. However, the recovery is facing challenges from COVID-19 outbreaks and the property market. We think further policy easing is needed to stabilize growth.
  • Manufacturing activity was a pillar of support for the economy in terms of both production (+3.4% y-o-y) and investment (+9.9% y-o-y). This is due to a combination of still resilient exports demand, a continued domestic recovery, and further easing of domestic supply chain bottlenecks. Looking ahead, we expect global demand to slow in the coming quarters, but we still expect to see strong growth in medium and high-tech manufacturing activity on the back of strong structural factors and policy support.
  • Infrastructure investment picked up further in June, rising 11% y-o-y. This follows on accelerated issuance of special local government bonds, with almost all of the issuance completed by June. Infrastructure investment is likely to sustain strong momentum in the coming months on the back of guidance to use these proceeds by the end of August as well as further policy funding.
  • Exports surged again, rising 17.9% y-o-y in June boosted by the resumption of work following better domestic containment of COVID-19 and a weaker RMB in recent months. Meanwhile, imports rose by a more meagre 1.0% y-o-y, down from 4.1% y-o-y in May, on the back of still elevated global commodity prices and only a gradual recovery in domestic activity. The trade surplus rose to a new record high of USD97.9bn.
  • Consumer Price Index (CPI) inflation moved up to 2.5% y-o-y in June, from 2.1% in May. Improved logistics conditions and an increase of production due to warmer weather have added to the supply of vegetables, fruits, and eggs, and hence led to a fall in their prices. Non-food prices, on the contrary, extended another 0.3ppt rise, attributable to both rising oil prices and possibly some recovery of service consumption (e.g. higher hotel prices).

Thematic article: 2022 vs 2020: COVID-19 waves and policy responses

We expect a moderate rebound in H2

With COVID-19 outbreaks in 2020 and 2022 creating economic headwinds in China, we compare the periods and find that policy support is largely comparable, helping to pave the way for a moderate rebound in H2 2022. We expect the current easing stance to remain for the rest of the year, with additional measures on the table, too.

2022 vs 2020

The nature of the recovery will depend on policy support

China’s economy is well on its way to recovery. The latest Omicron wave is receding, mobility restrictions are gradually lifting, and activity levels have been bouncing back. However, looking ahead, the pace and strength of the recovery will depend on the implementation of policy support in the coming quarters. To give us a better idea of what shape the recovery is likely to take, we compare the policy responses between this latest wave and the initial outbreak in 2020, using three key measures:

1. COVID-19 cases – Case numbers during this wave are higher, but the economic damage has not been as deep as in 2020, when country-wide restrictions were implemented. Still, this time around, the impact has been broader, with more cities facing COVID-19 waves, and it has taken longer to fully resume activities.

2. Fiscal stimulus – Fiscal policy has played a key role in both rounds of COVID-19 waves. Many measures are on par, including tax cuts (RMB2.64trn in 2022 vs RMB2.6trn in 2020) and special local government bond issuance (RMB3.65trn in 2022 vs RMB3.75trn in 2020).

3. Monetary easing – Monetary policy seems less punchy this time around when looking at headline figures such as policy rate cuts and relending quotas, which are smaller. But the People’s Bank of China (PBoC) still has room to remain accommodative given low inflation.

 

Policy impact can pick up the slack

On the whole, the policy package this time around from China is still substantial. Now, it comes down to implementation. With the latest COVID-19 wave better contained, we think the policy impact can pick up the slack, helping to pave the way for a moderate recovery in the second half of the year.

1. China's growth is likely to see a moderate recovery in H2

Source: CEIC, HSBC

2. Service and consumption have been hardest hit

Source: CEIC, HSBC

Key upcoming China economic data

Source: Refinitiv Eikon

Performance of key A-share indexes*

Note: * Past performance is not an indication of future returns. As of 28 July 2022 market close.

Source: Refinitiv Eikon

Additional disclosures

  1. This report is dated as at 29 July 2022.
  2. All market data included in this report are dated as at close 28 July 2022, unless a different date and/or a specific time of day is indicated in the report. 
  3. HSBC has procedures in place to identify and manage any potential conflicts of interest that arise in connection with its Research business. HSBC's analysts and its other staff who are involved in the preparation and dissemination of Research operate and have a management reporting line independent of HSBC's Investment Banking business. Information Barrier procedures are in place between the Investment Banking, Principal Trading, and Research businesses to ensure that any confidential and/or price sensitive information is handled in an appropriate manner.
  4. You are not permitted to use, for reference, any data in this document for the purpose of (i) determining the interest payable, or other sums due, under loan agreements or under other financial contracts or instruments, (ii) determining the price at which a financial instrument may be bought or sold or traded or redeemed, or the value of a financial instrument, and/or (iii) measuring the performance of a financial instrument or of an investment fund.

This document is prepared by The Hongkong and Shanghai Banking Corporation Limited (‘HBAP’), 1 Queen’s Road Central, Hong Kong. HBAP is incorporated in Hong Kong and is part of the HSBC Group. This document is distributed by HSBC Bank Canada, HSBC Bank (China) Company Limited, HSBC Continental Europe, HBAP, HSBC Bank (Singapore) Limited, HSBC Bank (Taiwan) Limited, HSBC Bank Malaysia Berhad (127776-V) / HSBC Amanah Malaysia Berhad (807705-X), The Hongkong and Shanghai Banking Corporation Limited, India, HSBC Bank Middle East Limited, HSBC UK Bank plc, HSBC Bank plc, Jersey Branch, and HSBC Bank plc, Guernsey Branch (collectively, the “Distributors”) to their respective clients. This document is for general circulation and information purposes only. This document is not prepared with any particular customers or purposes in mind and does not take into account any investment objectives, financial situation or personal circumstances or needs of any particular customer. HBAP has prepared this document based on publicly available information at the time of preparation from sources it believes to be reliable but it has not independently verified such information. The contents of this document are subject to change without notice. HBAP and the Distributors are not responsible for any loss, damage or other consequences of any kind that you may incur or suffer as a result of, arising from or relating to your use of or reliance on this document. HBAP and the Distributors give no guarantee, representation or warranty as to the accuracy, timeliness or completeness of this document. This document is not investment advice or recommendation nor is it intended to sell investments or services or solicit purchases or subscriptions for them. You should not use or rely on this document in making any investment decision. HBAP and the Distributors are not responsible for such use or reliance by you. You should consult your professional advisor in your jurisdiction if you have any questions regarding the contents of this document. You should not reproduce or further distribute the contents of this document to any person or entity, whether in whole or in part, for any purpose. This document may not be distributed to any jurisdiction where its distribution is unlawful.

The following statement is only applicable to HSBC Bank (Taiwan) Limited with regard to how the publication is distributed to its customers: HSBC Bank (Taiwan) Limited (“the Bank”) shall fulfill the fiduciary duty act as a reasonable person once in exercising offering/conducting ordinary care in offering trust services/ business. However, the Bank disclaims any guaranty on the management or operation performance of the trust business.

© Copyright 2022. The Hongkong and Shanghai Banking Corporation Limited, ALL RIGHTS RESERVED. No part of this document may be reproduced, stored in a retrieval system, or transmitted, on any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of The Hongkong and Shanghai Banking Corporation Limited.